NMG Q1 2026 Earnings Narrowing Losses and Strategic Progress in Graphite Production Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Booz Allen Hamilton Q1 2026 Earnings EPS Crushes Estimates as Government Contractor Delivers Strong Operational Results NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances Timken Q1 2026 Earnings EPS Surprises to the Upside as Operational Discipline Drives Results